Inclusion Criteria:  age between 19 to 45 years; body weight more than 50 kg  Exclusion Criteria:  a history or evidence of hepatic, renal, gastrointestinal, or hematological abnormality; hepatitis B, hepatitis C, syphilis, or HIV infection; a history of hypersensitivity to dapagliflozin and/or linagliptin; clinically significant allergic disease; alcohol or drug abuse; heavy smoker (more than ten cigarettes per day); use of any medication within 30 days before the start of the study that may affect the study results.